ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0991

Comparing the Prevalence of Sarcoidosis in Canadian Rural, Urban, and Farming Populations

Varinder Hans1, Don Voaklander1, C. Allyson Jones2 and Elaine Yacyshyn2, 1University of Alberta, Edmonton, Canada, 2University of Alberta, Edmonton, AB, Canada

Meeting: ACR Convergence 2024

Keywords: Epidemiology, Inflammation, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Sarcoidosis is a granulomatous inflammatory response thought to be due to a dysregulated immune response to environmental antigens.1 The prevalence of sarcoidosis varies geographically. There is evidence of increased prevalence among rural communities in the United States particularly in communities with prominent lumber industries.2,3 Use of wooden stoves and farm milk have been associated with rural communities and increased risk of sarcoidosis.3,4 Alberta is a Canadian province with the second-largest number of farmers in Canada. The main type of farming in Alberta includes oilseed and grain farming (34.3%), beef and feedlots (20.9%), dairy and milk (5%).5 The purpose of this study is to compare the prevalence of sarcoidosis among rural, urban and farm populations within Alberta, Canada.

Methods: This retrospective epidemiological study used a database from Alberta Health Services containing anonymous data from patients in Alberta, Canada. Alberta Health created a farm cohort through probabilistic matching with Alberta Agriculture, and Rural Development and the Farm Fuel Tax subsidy. Our population included all adults over the age of 18 years. Sarcoidosis was identified by ICD-10-CA based diagnosis. We also used the Alberta Health Care Insurance Plan (AHCIP), Discharge Abstract Database, Physician Claims and Alberta Vital Statistics to determine the patient’s sex, age, date of birth, geographical residence (rural or urban or farm), initial sarcoidosis diagnosis source, age of diagnosis, hospitalizations, Emergency Department visits, Coronary Care Unit visits, Intensive Care Unit visits and mortality. Descriptive statistics was used for data analysis of the matched population groups (rural, urban, and farm).

Results: Of the 417,288 patients identified, the urban population (137,348) had 432 cases of sarcoidosis identified (19.8 per 100,000) with an average age of diagnosis of 47.6 (SD 16.6) years. Of the rural population (138,043), 229 cases of sarcoidosis were identified (16.9 per 100,000) with an average age at time of diagnosis of 47.7 (SD 18.4). Of the farm population (141,897), 462 cases of sarcoidosis (20.4 per 100,000) were identified with an average age of diagnosis of 52.4 (SD 17.1) years of age. No statistically significant differences were seen between these populations. In patients with sarcoidosis, the most common cause of death was cancer (35%), followed by respiratory diseases (19%) and diseases of the circulatory system (16%). There was no significant risk for lung cancer mortality in patients with sarcoid lung disease.

Conclusion: Sarcoidosis is an inflammatory disease that we still have much to learn about. Comparing the prevalence of disease among different populations can be useful in identifying potential risk factors of disease for further investigation. Previous studies have identified increased prevalence of sarcoidosis among rural populations. In contrast, this study demonstrates no significant difference in the prevalence of sarcoidosis among the rural, urban and farm populations within Alberta, Canada.

Supporting image 1


Disclosures: V. Hans: None; D. Voaklander: None; C. Jones: None; E. Yacyshyn: Otsuka Canada, 6, Sobi, 6.

To cite this abstract in AMA style:

Hans V, Voaklander D, Jones C, Yacyshyn E. Comparing the Prevalence of Sarcoidosis in Canadian Rural, Urban, and Farming Populations [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/comparing-the-prevalence-of-sarcoidosis-in-canadian-rural-urban-and-farming-populations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparing-the-prevalence-of-sarcoidosis-in-canadian-rural-urban-and-farming-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology